BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Ewing Morris & Co. Investment Partners Ltd.'s Holding History (CIK: 0001846838)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,000,000 Value ($000) $2,493 Avg Close — Range —
Q3 2024
Shares 2,000,000 Value ($000) $2,282 Avg Close — Range —